GRAPHITE BIO
Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicine’s most elusive goals: to precisely “find & replace” any gene in the genome. Graphite Bio’s platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations.
GRAPHITE BIO
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.graphitebio.com
Total Employee:
101+
Status:
Active
Total Funding:
195.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Generate Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series B - Graphite Bio
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Series B - Graphite Bio
RA Capital Management
RA Capital Management investment in Series B - Graphite Bio
Samsara BioCapital
Samsara BioCapital investment in Series B - Graphite Bio
Versant Ventures
Versant Ventures investment in Series B - Graphite Bio
Surveyor Capital
Surveyor Capital investment in Series B - Graphite Bio
OrbiMed
OrbiMed investment in Series B - Graphite Bio
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Graphite Bio
Rock Springs Capital
Rock Springs Capital investment in Series B - Graphite Bio
Deerfield
Deerfield investment in Series B - Graphite Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-02 | Graphite Bio Appoints Alethia Young as Chief Financial Officer |
Official Site Inspections
http://www.graphitebio.com Semrush global rank: 2.95 M Semrush visits lastest month: 5.52 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
